1 |
Gini G, Franchi AM, Manganaro A, Golbamaki A, Benfenati E (2014) ToxRead: a tool to assist in read across and its use to assess mutagenicity of chemicals. SAR QSAR Environ Res 25:999-1011. https://doi.org/10.1080/1062936X.2014.976267
DOI
|
2 |
Gibney MJ, Lanham-New SA, sidy A, Vorster HH (2009) Introduction to human nutrition. Wiley, Chichester
|
3 |
Kristl J, Abramovie Z, Sentjure M (2003) Skin oxygenation after topical application of liposome-entrapped benzyl nicotinate as measured by EPR oximetry in vivo: influence of composition and size. AAPS Pharm Sci 5:19-27. https://doi.org/10.1208/ps050102
DOI
|
4 |
Koivukangas V, Oikarinen A, Salmela PI, Lahti A (2000) Microcirculatory response of skin to benzoic acid and methyl nicotinate in patients with diabetes. Diabet Med 17:130-133. https://doi.org/10.1046/j.1464-5491.2000.00248.x
DOI
|
5 |
Matthews P, Derry S, Moore RA, McQuay HJ (2009) Topical rubefacients for acute and chronic pain in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007403.pub2
DOI
|
6 |
Zaretzki J, Matlock M, Swamidass SJ (2013) XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks. J Chem Inf Model 53:3373-3383. https://doi.org/10.1021/ci400518g
DOI
|
7 |
US EPA (2012) Estimation Programs Interface SuiteTM (EPI Suite) for Microsoft VRWindows, v.4.1. United States Environmental Protection Agency, Washington
|
8 |
Naumann BD, Weideman PA (1995) Scientific basis for uncertainty factors used to establish occupational exposure limits for pharmaceutical active ingredients. Hum Ecol Risk Assess 1:590-613. https://doi.org/10.1080/10807039509380049
DOI
|
9 |
IdeaConsult (2015) Toxtree (v.3.1.0) Toxic Hazard Estimation by Decision Tree Approach
|
10 |
Varsou DD, Melagraki G, Sarimveis H, Afantitis A (2017) MouseTox: an online toxicity assessment tool for small molecules through Enalos Cloud platform. Food Chem Toxicol 110:83-93. https://doi.org/10.1016/j.fct.2017.09.058
DOI
|
11 |
World Health Organization (WHO) (2001) Guidance document for the use of data in development of chemical-specific adjustment factors (CSAFs) for interspecies differences and human variability in dose/concentration-response assessment. WHO/PCS/01.4. pp 1-77
|
12 |
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH harmonized tripartite guideline. Impurities: guideline for residual solvents Q3C(R5). https://www.pmda.go.jp/files/000156308.pdf. Accessed 15 July 2020
|
13 |
EMEA (1998) Methyl nicotinate-summary report. Committee for veterinary medicinal products. EMEA/MRL/465/98-Final. https://s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/063/original/WC500015074.pdf?1526077961. Accessed 15 July 2020
|
14 |
Petley AM, Wilkin TJ (1992) Oral nicotinamide impairs growth of rats. Diabetologia 35:A202
|
15 |
Patlewicz G, Ball N, Booth ED, Hulzebos E, Zvinavashe E, Hennes C (2013) Use of category approaches, read-across and (Q)SAR: general considerations. Regul Toxicol Pharmacol 67:1-12. https://doi.org/10.1016/j.yrtph.2013.06.002
DOI
|
16 |
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH harmonized tripartite guideline. Impurities: guideline for residual solvents Q3C (R6). https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3C/Q3C__R6___Step_4.pdf. Accessed 20 July 2020
|
17 |
Sussman RG, Naumann BD, Pfister T, Sehner C, Seaman C, Weideman PA (2016) A harmonization effort for acceptable daily exposure derivation-considerations for application of adjustment factors. Regul Toxicol Pharmacol 79:S57-S66. https://doi.org/10.1016/j.yrtph.2016.05.023
DOI
|
18 |
Pharmaceutical Inspection Convention, Co-Operation Scheme (PIC/S), Guide to good manufacturing practice for medicinal products, Annex 15. PS/INF 11/2015; 1 April 2015. https://picscheme.org/layout/document.php?id=118. Accessed 15 July 2020
|
19 |
Lovsin Barle E, Bizec JC, Glogovac M, Gromek K, Winkler GC (2018) Determination and application of the permitted daily exposure (PDE) for topical ocular drugs in multipurpose manufacturing facilities. Pharm Dev Technol 23:225-230. https://doi.org/10.1080/10837450.2017.1312442
DOI
|
20 |
Tugcu G, Charehsaz M, Aydin A (2019) Toxicological evaluation of ergocalciferol, cholecalciferol, and their metabolites by a category approach. Drug Chem Toxicol. https://doi.org/10.1080/01480545.2019.1650061
DOI
|
21 |
ECHA. Read-across Assessment Framework (RAAF). ECHA, Helsinki, Finland ECHA-17-R-01-EN. https://echa.europa.eu/documents/10162/13628/raaf_en.pdf. Accessed 18 July 2020
|
22 |
European Commission. Opinion of the scientific committee on food on the tolerable upper intake level of nicotinic acid and nicotinamide. https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_scf_out80j_en.pdf. Accessed 18 July 2020
|
23 |
Benigni R, Bossa C, Tcheremenskaia O, Battistelli CL, Crettaz P (2012) The new ISSMIC database on in vivo micronucleus and its role in assessing genotoxicity testing strategies. Mutagenesis 27:87-92. https://doi.org/10.1093/mutage/ger064
DOI
|
24 |
EPA. Inert reassessment of nicotinamide. https://www.epa.gov/sites/production/files/2015-04/documents/nicotinamide.pdf. Accessed 20 July 2020
|
25 |
US EPA (2016) Toxicity Estimation Software Tool (T.E.S.T.), v.4.2.1. United States Environmental Protection Agency, Washington
|
26 |
Ji C, Svensson F, Zoufir A, Bender A (2018) eMolTox: prediction of molecular toxicity with confidence. Bioinformatics 34:2508-2509. https://doi.org/10.1093/bioinformatics/bty135
DOI
|
27 |
Braga RC, Alves VM, Muratov EN et al (2017) Pred-Skin: a fast and reliable web application to assess skin sensitization effect of chemicals. J Chem Inf Model 57:1013-1017. https://doi.org/10.1021/acs.jcim.7b00194
DOI
|
28 |
Unna K (1939) Studies on the toxicity and pharmacology of nicotinic acid. J Pharmacol Exp Ther 65:95-103
|
29 |
Handler P, Dann WJ (1942) The inhibition of rat growth by nicotinamide. J Biol Chem 146:357-368
DOI
|
30 |
Horger LM, Gerheim EB (1958) Effects of excess dietary methionine and niacinamide in the rat. Proc Soc Exp Biol Med 97:444-446. https://doi.org/10.3181/00379727-97-23769
DOI
|
31 |
Schoental R (1977) The role of nicotinamide and of certain other modifying factors in diethylnitrosamine carcinogenesis: fusaria mycotoxins and "spontaneous" tumors in animals and man. Cancer 40:1833-1840. https://doi.org/10.1002/1097-0142(197710)40:4+<1833::aid-cncr2820400810>3.0.co;2-l
DOI
|
32 |
EMA (2014) Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities. EMA/CHMP/CVMP/SWP/169430/2012. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-setting-health-based-exposure-limits-use-riskidentification-manufacturedifferent_en.pdf. Accessed 15 July 2020
|
33 |
Roe FJC (1964) Effect of massive doses of riboflavin, and other vitamins of the B group, on skin carcinogenesis in mice. Br J Cancer 16:252-257. https://doi.org/10.1038/bjc.1962.29
DOI
|
34 |
Rakieten N, Gordon BS, Beaty A, Cooney DA, Schein PS, Dixon RL (1976) Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes. Proc Soc Exp Biol Med 151:356-361. https://doi.org/10.3181/00379727-151-39209
DOI
|
35 |
Toth B (1983) Lack of carcinogenicity of nicotinamide and isonicotinamide following lifelong administration to mice. Oncology 40:72-75. https://doi.org/10.1159/000225695
DOI
|
36 |
Lahti A, Maibach HI (1984) An animal model for nonimmunologic contact urticaria. Toxicol Appl Pharmacol 76:219-224. https://doi.org/10.1016/0041-008X(84)90002-4
DOI
|